N-SIDE announces the growing collaboration with Galapagos

Share Article
Sylvia Haller

N-SIDE, provider of innovative software and strategic consulting services, is pleased to announce the growing collaboration with Galapagos NV, biotechnology company.

Galapagos has signed a contract to use the N-SIDE Suite for Clinical Trials (specifically the N-SIDE Supply and  Dashboard apps). By combining this innovative SaaS solution and N-SIDE consulting services, they will optimize clinical trial supply chain planning while managing risk and controlling study budgets. In addition, Galapagos will use N-SIDE strategic consulting services for production optimization to ensure an efficient planning of their end-to-end clinical trial supply chain.

“Galapagos and N-SIDE are both fast growing Belgian companies, and we are proud to help Galapagos take end-to-end clinical supply chain planning and optimization to the next level with the N-SIDE Suite for Clinical Trials,” stated Jacques Parlongue, N-SIDE CEO.

Galapagos and N-SIDE started the collaboration in 2018 with N-SIDE providing consulting services for clinical trial supply optimization.

The N-SIDE Suite for Clinical Trials is a cutting-edge, cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial planning and monitoring with real-time data and knowledge sharing.

Learn more about the N-SIDE Suite

About the Author

Life Sciences Marketing Manager

Sylvia Haller